PRODUCT CENTER


our products have been exported to more than 30 countries including North America, South America, Europe, Middle East & Southeast Asia.

Shandong Qilu King-Phar Pharmaceutical Co., Ltd.


As a member of QILU PHARMACEUTICAL GROUP , Shandong Qilu King-Phar Pharmaceutical Co., Ltd.  is the location of our fermentation processing plant , one of 8 sites specializing in production of antibiotic API and premixes. covering an area of over 20,000 square meters with production capacity over 10000 metric tons. Qilu King-phar has an integrated and stringent system of quality control and quality assurance. We are fully committed to the quality of our products. Our products have passed the Chinese GMP inspection, and some of the products have been approved by USFDA, EDQM, APVMA and other national regulatory authorities. With the continuous expansion of international business, the company has built cooperation with many big multinationals, our products have been exported to more than 30 countries including North America, South America, Europe, Middle East & Southeast Asia. 

Shandong Qilu King-Phar Pharmaceutical Co., Ltd.

NEWS CENTER


07-01

2020

2020 Environmental Emergency Drill

2020 Environmental Emergency Drill

03-23

2019

The company once again passed the FDA inspection with zero defects

On March 23, 2017, the FDA inspector solemnly announced that Shandong Qifa Pharmaceutical Co., Ltd. will conduct a zero-defect on-site inspection! This is the 5th FDA inspection in the history of Qifa Pharmaceutical, and the 3rd time with zero defects.

09-16

2021

Information Disclosure of Hazardous Waste Pollution Prevention and Control

Information Disclosure of Hazardous Waste Pollution Prevention and Control

11-10

2018

Emergency drill for environmental emergencies

Emergency drill for environmental emergencies

09-22

2019

2019 Environmental Emergency Drill

2019 Environmental Emergency Drill

03-28

2022

Environmental Information Disclosure

Environmental Information Disclosure